JP Morgan Upgrades MorphoSys to Overweight, Raises Price Target to $10
Portfolio Pulse from richadhand@benzinga.com
JP Morgan analyst Richard Vosser upgraded MorphoSys (NASDAQ:MOR) from Underweight to Overweight and raised the price target from $3.3 to $10.
June 16, 2023 | 9:03 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan upgraded MorphoSys to Overweight and raised its price target from $3.3 to $10.
The upgrade from Underweight to Overweight by JP Morgan analyst Richard Vosser indicates a positive outlook for MorphoSys. The significant increase in the price target from $3.3 to $10 suggests that the analyst believes the stock has strong growth potential in the short term. This news is likely to have a positive impact on the stock price as investors may see it as a signal to buy.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100